The knockdown of PCAF enhanced the binding affinity of HOXB9 to the SLC7A11 promoter, whereas PCAF overexpression inhibited HOXB9 binding, thereby downregulating SLC7A11 expression and suppressing the growth and progression of NSCLC [21]. The gene discussed is KAT2B; the disease is non-small cell lung carcinoma.